Cellxpert Biotechnology

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Cellxpert Biotechnology sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials none currently recruiting 3 completed early-phase tilt upper quartile by trial count

Cellxpert Biotechnology: 3 sponsored US clinical trials, none currently recruiting.

Cellxpert Biotechnology sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Unspecified Adult Solid Tumor, Protocol Specific, with 1 trials.

Upper-quartile sponsor footprint

Cellxpert Biotechnology sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

How the Cellxpert Biotechnology early-phase archive is shaped

3 indexed studies, none listed as recruiting (0% open); 3 completed (100%).

Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).

Top condition: Unspecified Adult Solid Tumor, Protocol Specific (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Cellxpert Biotechnology: archived-pipeline peers nationwide

Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Cellxpert Biotechnology sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share Cellxpert Biotechnology10xBio22nd Century GroupAA SecordAAADRS Clinical Research Center23andMe3-C Institute for Social Development3 Waves Wellness3EO Health
Cellxpert Biotechnology sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Cellxpert Biotechnology sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Cellxpert Biotechnology page

3 registered trials is a research-attention snapshot, not an endorsement of Cellxpert Biotechnology or any single study.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Cellxpert Biotechnology pipeline card: 3 registered trials from official public datasets.Report a data error.